Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Antiremodeling effect of long-term exercise training in patients with stable chronic heart failure: results of the Exercise in Left Ventricular Dysfunction and Chronic Heart Failure (ELVD-CHF) trial
Giannuzzi P, Temporelli PL, Corra U, Tavazzi L, ELVD-CHF Study Group
Circulation 2003 Aug 5;108(5):554-559
clinical trial
6/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

BACKGROUND: The effects of exercise training (ET) on left ventricular (LV) remodeling in chronic heart failure are not definitively established, and the safety of ET in these patients is still debated. METHODS AND RESULTS: This multicenter study investigated the long-term effect of moderate ET on LV remodeling, work capacity, and quality of life (QoL) in 90 patients with stable chronic heart failure caused by LV systolic dysfunction, randomized to a 6-month ET program (T, n = 45) or a control group (C, n = 45). All patients underwent resting echocardiography, a cardiopulmonary exercise test, 6-minute walking test, and QoL assessment at entry and after 6 months. At entry, end-diastolic (EDV) and end-systolic (ESV) volume, ejection fraction, work capacity, peak o2, and walking distance were similar in the 2 groups. After 6 months, LV volumes diminished in T (EDV, from 142 +/- 26 to 135 +/- 26 mL/m2, p < 0.006; ESV, from 107 +/- 24 to 97 +/- 24 mL/m2, p < 0.05) but increased in C (EDV, from 147 +/- 41 to 156 +/- 42 mL/m2, p < 0.01; ESV, from 110 +/- 34 to 118 +/- 34 mL/m2, p < 0.01). Ejection fraction improved in T (p < 0.001) but was unchanged in C (p = NS). Significant improvement in work capacity (p < 0.001), peak VO2 (p < 0.006), walking distance (p < 0.001), and QoL (p < 0.01) was observed in T but not in C (p = NS). T showed a trend toward fewer (p = 0.05) hospital readmissions for worsening dyspnea in the absence of other adverse cardiac events. CONCLUSIONS: In stable chronic heart failure, long-term moderate ET has no detrimental effect on LV volumes and function; rather, it attenuates abnormal remodeling. Furthermore, ET is safe and effective in improving exercise tolerance and QoL.
For more information on this journal, please visit http://www.lww.com.

Full text (sometimes free) may be available at these link(s):      help